Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02903, USA.
MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, UK; Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
Cell Rep. 2019 Apr 23;27(4):997-1007.e5. doi: 10.1016/j.celrep.2019.03.104.
Oncogene-induced senescence (OIS) is a tumor suppressive response to oncogene activation that can be transmitted to neighboring cells through secreted factors of the senescence-associated secretory phenotype (SASP). Currently, primary and secondary senescent cells are not considered functionally distinct endpoints. Using single-cell analysis, we observed two distinct transcriptional endpoints, a primary endpoint marked by Ras and a secondary endpoint marked by Notch activation. We find that secondary oncogene-induced senescence in vitro and in vivo requires Notch, rather than SASP alone, as previously thought. Moreover, Notch signaling weakens, but does not abolish, SASP in secondary senescence. Global transcriptomic differences, a blunted SASP response, and the induction of fibrillar collagens in secondary senescence point toward a functional diversification between secondary and primary senescence.
癌基因诱导的衰老(OIS)是一种针对癌基因激活的肿瘤抑制反应,可通过衰老相关分泌表型(SASP)的分泌因子传递到邻近细胞。目前,原发性和继发性衰老细胞不被认为是功能上不同的终点。通过单细胞分析,我们观察到两个不同的转录终点,一个以 Ras 为标志的原发性终点和一个以 Notch 激活为标志的继发性终点。我们发现,体外和体内的继发性癌基因诱导衰老需要 Notch,而不仅仅是以前认为的 SASP 单独作用。此外,Notch 信号通路削弱但没有消除次级衰老中的 SASP。全局转录组差异、SASP 反应迟钝以及次级衰老中纤维状胶原蛋白的诱导表明次级衰老和原发性衰老之间存在功能多样化。